Rafik Fellague-Chebra

Company: Novartis Oncology

Job title: Executive Global Group Medical Director

Seminars:

Fireside Chat: Unlocking Pharma & Investor Buy-In 10:00 am

Understanding the cautious approach of large pharma towards microbiome investments and the factors shaping their decisions Analyzing recent strategic partnerships and investment trends to uncover what drives value in microbiome-based innovations Discussing key considerations for forging successful partnerships with big pharma and aligning biotech strategies with industry needs to drive mutual growthRead more

day: Conference Day One - 7am to 10am

The Microbiome’s Role in Gastrointestinal Cancers 9:00 am

Exploring the Microbiome & Colorectal Cancer: How gut microbiota modulate colorectal cancer risk and progression, evaluating the influence of microbial metabolites (e.g., butyrate) on tumor microenvironment and elucidating microbiome interactions with immunotherapy and chemotherapy response Other GI Cancers (Pancreatic, Gastric & Esophageal): exploring key microbiome-driven mechanisms in upper GI cancers, the role of bacterial dysbiosis…Read more

day: Conference Day Two, 7:30 - 10:00

Start-Up Showcase 10:00 am

Start-Up Showcase Immerse yourself in a showcase of cutting-edge research and technologies as short-listed microbiome start-ups unveil their unique approaches to drug development. You, and a judging panel of experts, will meet the brilliant minds behind microbiome start-ups, understanding their expertise, commercial strategies for success and passion that drives their mission to revolutionize today’s drug…Read more

day: Conference Day Two, 7:30 - 10:00